Dallas, TX -- (SBWire) -- 07/12/2011 --The report analyzes the MarketsandMarkets : Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015) by technologies and applications and studies the major market drivers, restraints, and opportunities for the PET SPECT market in U.S., EMEA, and Asia-Pacific.

Propelled by the transparent reimbursement policies, new emerging economies, novel applications such as Alzheimer’s and continually expanding oncology application segment, the global positron emission tomography (PET) market is estimated to reach around $6.3 billion in 2010.

Reimbursement plays a major role in the adoption of any medical imaging technology. The approval of PET scanning reimbursement in the U.S.by the Medicare and Medicaid for the Alzheimer’s disease widened the opportunities for the major market participants. Currently, there are approximately 4.7 million Alzheimer’s patients in the U.S. PET enables the radiologist to have the early diagnosis of the Alzheimer disease among the patients. Therefore, this would further increase the demand of the PET scanners among the various health care centers.

Similarly, single photon emission computed tomography (SPECT) scanners have been on the forefront to bring about significant changes in the diagnostic imaging equipment landscape by opening up numerous lucrative opportunities in niche market such as neuroendocrine tumor imaging. Moreover, technological advancements such as attenuation correction and image acquisition/reconstruction tools have enhanced SPECT end users’ confidence in its diagnostic and prognostic capabilities. The global PET SPECT market is expected to grow from an estimated $6.5 billion in 2010 to $10.3 billion in 2015, at an estimated CAGR of 9.4% from 2010 to 2015. The PET segment is estimated to account for the largest share – i.e. 75% – of the overall PET SPECT installations at 3,691 units in 2010. This segment is expected to reach 6,390 units in 2015, at a CAGR of 11.6% for the same period.

The PET/CT segment accounted for the largest share – i.e. 97% – of the overall PET market at an estimated $6.1 billion in 2010. This segment is expected to reach $ 9.8 billion in 2015, at a CAGR of 9.8% for the period 2010 to 2015. Oncology and cardiology are the most significant applications of the PET SPECT market. Oncology accounts for about 90% of the PET market, whereas cardiology accounts for about 85% of SPECT application market. Neurological application of PET and SPECT is a niche market and is dependent on the development of appropriate radionuclides and tracers.

Scope of the report

This research report categorizes the global PET SPECT market on the basis of technology, application, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of technology:
Stand alone PET, PET/CT, stand alone SPECT and SPECT/CT
On the basis of application:
Oncology, non small cell lung cancer, Hodgkin and non Hodgkin lymphoma, head and neck cancer, colorectal cancer, breast cancer; cardiology and neurology
On the basis of geography:
U.S., EMEA (Europe, Middle East andAfrica), Asia-Pacific and Rest of the world

Browse market data tables and in-depth TOC on Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015).

Early buyers will receive 10% customization of reports.
Browse All : PET Market
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html

About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in theU.S.We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets